Realtime Data Files Third Suit Against Oracle in Data Compression Campaign
Realtime Data LLC has added a third Texas case against Oracle (6:17-cv-00046) to its data compression campaign, now in its ninth year of litigation, asserting eight patents (6,597,812; 6,748,457; 7,358,867; 7,376,772; 8,502,707; 8,643,513; 8,717,204; 9,054,728) against various products related to data storage and networking. Oracle systems and services using certain database compression technologies are at issue, with those utilizing the company’s Hybrid Columnar Compression technology alleged to infringe the ‘812, ‘867, ‘707, ‘513, ‘204, and ‘728 patents and those incorporating its Advanced Row Compression feature further accused of infringing the ‘867 patent. The ‘867 patent is also asserted against Oracle’s Essbase, a platform for business analytics, modeling, and forecasting. In addition, the complaint targets certain servers and storage hardware, with the Oracle SPARC Solaris alleged to infringe the ‘457 patent and the company’s ZFS Storage Appliance accused of infringing the ‘722 patent.
Subscription Required
This content requires a subscription to view
- Over 7,000 news articles covering new patent cases, key policy decisions, and USPTO assignments
- Advanced custom alerts for campaigns and entities
- Proprietary litigation timelines
- Full access to Federal Circuit, PTAB, and ITC dockets
- Judge, venue, and law firm analytics
Related News
Details
Key Parties
Campaigns
Litigations
- REALTIME DATA, LLC d/b/a IXO v. Thomson Reuters et al
- Realtime Data, LLC d/b/a IXO v. Thomson Reuters et al
- Realtime Data, LLC d/b/a IXO v. Thomson Reuters Corporation et al
- REALTIME DATA, LLC D/B/A/ IXO, v. CME Group Inc. et al
- REALTIME DATA, LLC d/b/a IXO v. Thomson Reuters Corporation et al
- REALTIME DATA, LLC D/B/A/ IXO, v. Morgan Stanley et al
- REALTIME DATA, LLC d/b/a IXO v. PACKETEER, INC. et al
- Realtime Data, LLC d/b/a IXO v. CME Group Inc. et al
- Realtime Data, LLC D/B/A/ IXO, v. Morgan Stanley et al
- Realtime Data, LLC d/b/a IXO v. CME Group Inc. et al